Literature DB >> 19411841

Serotonin receptor 2C and mental disorders: genetic, expression and RNA editing studies.

Kazuya Iwamoto1, Miki Bundo, Tadafumi Kato.   

Abstract

Serotonin receptor 2C (HTR2C) is one of the attractive candidate genes for studying pathophysiology of mental disorders. Here we overviewed the genetic, expression and RNA editing studies suggesting the close relationship between HTR2C and major mental disorders including schizophrenia, bipolar disorder and major depression. We especially focused on the human studies as well as with reference to relevant cellular and animal models. Possible significance of genetic variations affecting expression and RNA editing and appropriate animal models that mimic human mental disorders were discussed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19411841     DOI: 10.4161/rna.6.3.8370

Source DB:  PubMed          Journal:  RNA Biol        ISSN: 1547-6286            Impact factor:   4.652


  25 in total

Review 1.  Serotonin receptor signaling and regulation via β-arrestins.

Authors:  Laura M Bohn; Cullen L Schmid
Journal:  Crit Rev Biochem Mol Biol       Date:  2010-10-07       Impact factor: 8.250

2.  Development of the 5-HT2CR-Tango System Combined with an EGFP Reporter Gene.

Authors:  Yoshihisa Watanabe; Atsushi Tsujimura; Miku Aoki; Katsutoshi Taguchi; Masaki Tanaka
Journal:  J Mol Neurosci       Date:  2015-09-15       Impact factor: 3.444

3.  Transcriptional architecture of the primate neocortex.

Authors:  Amy Bernard; Laura S Lubbers; Keith Q Tanis; Rui Luo; Alexei A Podtelezhnikov; Eva M Finney; Mollie M E McWhorter; Kyle Serikawa; Tracy Lemon; Rebecca Morgan; Catherine Copeland; Kimberly Smith; Vivian Cullen; Jeremy Davis-Turak; Chang-Kyu Lee; Susan M Sunkin; Andrey P Loboda; David M Levine; David J Stone; Michael J Hawrylycz; Christopher J Roberts; Allan R Jones; Daniel H Geschwind; Ed S Lein
Journal:  Neuron       Date:  2012-03-21       Impact factor: 17.173

4.  Cell type-specific in vivo expression of genes encoding signalling molecules in the brain in response to chronic mild stress and chronic treatment with fluoxetine.

Authors:  Lu Dong; Baoman Li; Alexei Verkhratsky; Liang Peng
Journal:  Psychopharmacology (Berl)       Date:  2015-04-09       Impact factor: 4.530

5.  Yohimbine as a Starting Point to Access Diverse Natural Product-Like Agents with Re-programmed Activities against Cancer-Relevant GPCR Targets.

Authors:  Nicholas G Paciaroni; Verrill M Norwood; Ranjala Ratnayake; Hendrik Luesch; Robert W Huigens
Journal:  Bioorg Med Chem       Date:  2020-05-07       Impact factor: 3.641

6.  Striatal dopamine release and genetic variation of the serotonin 2C receptor in humans.

Authors:  Brian J Mickey; Benjamin J Sanford; Tiffany M Love; Pei-Hong Shen; Colin A Hodgkinson; Christian S Stohler; David Goldman; Jon-Kar Zubieta
Journal:  J Neurosci       Date:  2012-07-04       Impact factor: 6.167

7.  In vitro screening for drug-induced depression and/or suicidal adverse effects: a new toxicogenomic assay based on CE-SSCP analysis of HTR2C mRNA editing in SH-SY5Y cells.

Authors:  Laurent Cavarec; Laurent Vincent; Claudia Le Borgne; Camille Plusquellec; Nathalie Ollivier; Priscilla Normandie-Levi; Frédéric Allemand; Nicolas Salvetat; Eve Mathieu-Dupas; Franck Molina; Dinah Weissmann; Jean-François Pujol
Journal:  Neurotox Res       Date:  2012-04-13       Impact factor: 3.911

8.  Genome-wide identification and characterization of fixed human-specific regulatory regions.

Authors:  Davide Marnetto; Ivan Molineris; Elena Grassi; Paolo Provero
Journal:  Am J Hum Genet       Date:  2014-07-03       Impact factor: 11.025

9.  Enhancement of alcohol drinking in mice depends on alterations in RNA editing of serotonin 2C receptors.

Authors:  Yoshihisa Watanabe; Kanji Yoshimoto; Harutsugu Tatebe; Masakazu Kita; Kazuko Nishikura; Minoru Kimura; Masaki Tanaka
Journal:  Int J Neuropsychopharmacol       Date:  2013-12-17       Impact factor: 5.176

10.  Exploration of synthetic approaches and pharmacological evaluation of PNU-69176E and its stereoisomer as 5-HT2C receptor allosteric modulators.

Authors:  Chunyong Ding; Nicole M Bremer; Thressa D Smith; Patricia K Seitz; Noelle C Anastasio; Kathryn A Cunningham; Jia Zhou
Journal:  ACS Chem Neurosci       Date:  2012-04-19       Impact factor: 4.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.